Cure pharmaceutical provided full corporate update on recent shareholder call

Oxnard, calif., aug. 09, 2022 (globe newswire) -- cure pharmaceutical holding corp. (otc: curr) (“cure”), a proprietary platform technology company, today announced that the company hosted a shareholder call on wednesday, august 3, 2022. on the recorded call/webcast, the executive management team provided details on the recent $20 million non-dilutive sale of a portion of its product and intellectual property portfolio and provided a full business update.
CURR Ratings Summary
CURR Quant Ranking